Core Viewpoint - A class action lawsuit has been filed against Picard Medical, Inc. (PMI) for alleged fraudulent activities affecting investors who purchased shares between September 2, 2025, and October 31, 2025 [2][7]. Allegation Details - The lawsuit claims that Picard failed to disclose critical information, including involvement in a fraudulent stock promotion scheme, the use of offshore accounts for share dumping, and omissions in public statements regarding false rumors and artificial trading activity [7]. Stock Performance - On October 24, 2025, Picard's stock price plummeted by 70%, dropping to $3.99 per share, and has since continued to decline to approximately $2.00 per share [7]. Legal Process - Investors have until April 3, 2026, to apply to the Court to be appointed as lead plaintiff in the lawsuit [2]. Contact Information - Investors seeking more information or wishing to discuss their legal rights can contact Bragar Eagel & Squire, P.C. at (212) 355-4648 or via email [4][8].
PICARD ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Picard Medical, Inc. and Encourages Investors to Contact the Firm
Globenewswire·2026-02-04 19:49